The LigaSure™ RAS Maryland jaw vessel sealer has arrived in the U.S.
Driven by the technology trusted by surgeons in over 45 million procedures,† the LigaSure™ RAS Maryland jaw device brings reliable vessel sealing to the world of robotic-assisted surgery.‡,1 Paired with the flexibility of the Hugo™ robotic-assisted surgery (RAS) system, LigaSure™ technology serves as the key to unlock more choice in the OR.
The LigaSure™ RAS Maryland jaw vessel sealer is the first robotically driven LigaSure™ instrument, combining the reliable vessel sealing of the ValleyLab™ FT10 generator with the versatility of the Hugo™ RAS system.2,3
The LigaSure™ RAS Maryland jaw vessel sealer is available exclusively on the Hugo™ RAS system, which enables wider adoption of minimally invasive surgery and its benefits.
Explore more ways LigaSure™ technology and the Hugo™ RAS system are redefining robotics, together.
Frequently asked questions (FAQ) about the LigaSure™ (RAS) Maryland jaw vessel sealer.
The LigaSure™ RAS Maryland jaw vessel sealer has similar jaw specifications, vessel sealing performance, and seal reliability as the LigaSure™ Maryland jaw vessel sealer.
The LigaSure™ RAS Maryland jaw vessel sealer has a longer cord (20 feet, 6 meters) to allow for robotic arm positioning and different instrument housing that allows it to be connected to the Hugo™ RAS system.
Yes, visual cues are provided on the surgeon console and system tower screen in addition to audible cues from the generator (see images below).6
Yes. It is important to ensure that the jaws remain fully closed when using the seal and/or cut function with the LigaSure™ RAS Maryland jaw vessel sealer.
If the jaws are not fully closed, the energy status module will only display outlined boxes in their respective colors, indicating that the instrument is not yet ready for energy activation (see below).6
The below visual confirmation will appear on the screen when proper jaw closure is achieved before energy is applied.6
Stay updated on the Hugo™ robotic-assisted
surgery (RAS) system.
Sign up now to continue learning from the experts who are building best practices in
RAS training and program development.
Surgeries using this instrument carry some residual risk, even when used by trained physicians. The potential adverse events associated with the use of this device include, but are not limited to; airway obstruction, allergic reaction, arrhythmia, bleeding, burns (including thermal and bowel), carcinogen exposure, cardiac arrest, electric shock, foreign body in patient, infection, nerve damage, perforation (including vessel and organ), thromboembolism, and tissue trauma. Use of this equipment without specific procedure training may result in serious unintended patient injury.
The Hugo™ RAS system was evaluated for its effectiveness and safety of specific procedures as a surgical tool for controlling robotic instruments, but not for clinical outcomes related to cancer or other diseases. The potential adverse events associated with the use of robotically assisted surgical devices include, but are not limited to: arrhythmia, bleeding, blunt trauma, bowel perforation, burns (varying degrees, bowel, thermal), crushing injury, delay of treatment (prolonged procedure), electric shock, foreign body in patient, infection, inflammation, tissue damage/trauma, toxicity, or vessel perforation. Please refer to the Hugo™ RAS system user guide and the Hugo™ RAS system indications document for complete indications, contraindictions and risk information.
† Based on internal sales data from FY01–FY27.
‡ 16 of 16 surgeons surveyed after use agreed. May not be indicative of clinical performance.
§ Bench tissue and animal model may not be indicative of clinical tissue performance.
◊ 15 of 16 surgeons surveyed after use agreed.
